ATE136777T1 - Behandlung von schlafstörungen unter verwendung bestimmter antidepressiva, z.b. nefazodon - Google Patents
Behandlung von schlafstörungen unter verwendung bestimmter antidepressiva, z.b. nefazodonInfo
- Publication number
- ATE136777T1 ATE136777T1 AT91120587T AT91120587T ATE136777T1 AT E136777 T1 ATE136777 T1 AT E136777T1 AT 91120587 T AT91120587 T AT 91120587T AT 91120587 T AT91120587 T AT 91120587T AT E136777 T1 ATE136777 T1 AT E136777T1
- Authority
- AT
- Austria
- Prior art keywords
- nefazodone
- treatment
- sleep disorders
- certain antidepressants
- antidepressants
- Prior art date
Links
- 239000000935 antidepressant agent Substances 0.000 title abstract 2
- 229940005513 antidepressants Drugs 0.000 title abstract 2
- 229960001800 nefazodone Drugs 0.000 title abstract 2
- VRBKIVRKKCLPHA-UHFFFAOYSA-N nefazodone Chemical compound O=C1N(CCOC=2C=CC=CC=2)C(CC)=NN1CCCN(CC1)CCN1C1=CC=CC(Cl)=C1 VRBKIVRKKCLPHA-UHFFFAOYSA-N 0.000 title abstract 2
- 208000019116 sleep disease Diseases 0.000 title 1
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/620,696 US5116852A (en) | 1990-12-03 | 1990-12-03 | Treatment of sleep disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE136777T1 true ATE136777T1 (de) | 1996-05-15 |
Family
ID=24487000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91120587T ATE136777T1 (de) | 1990-12-03 | 1991-11-29 | Behandlung von schlafstörungen unter verwendung bestimmter antidepressiva, z.b. nefazodon |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5116852A (de) |
| EP (1) | EP0493687B1 (de) |
| JP (1) | JP3062974B2 (de) |
| AT (1) | ATE136777T1 (de) |
| CA (1) | CA2056201A1 (de) |
| DE (1) | DE69118859T2 (de) |
| DK (1) | DK0493687T3 (de) |
| ES (1) | ES2087217T3 (de) |
| GR (1) | GR3019692T3 (de) |
| IL (1) | IL100183A (de) |
| MX (1) | MX9101994A (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5256664A (en) * | 1992-04-28 | 1993-10-26 | Bristol-Myers Squibb Company | Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones |
| US5502047A (en) * | 1993-03-22 | 1996-03-26 | Kavey; Neil B. | Treatment for insomnia |
| EP0769297A1 (de) | 1995-10-17 | 1997-04-23 | Bristol-Myers Squibb Company | Verwendung von Nefazodon für die Herstellung eines Medikaments zur Behandlung von Panikanfällen |
| US5854248A (en) * | 1996-07-31 | 1998-12-29 | Bristol-Myers Squibb Company | Nefazodone: use in migraine prophylaxis |
| US5852020A (en) * | 1996-11-22 | 1998-12-22 | Bristol-Myers Squibb Company | Nefazodone: use in treating post traumatic stress disorder |
| US6008222A (en) * | 1996-12-04 | 1999-12-28 | Bristol-Myers Squibb Company | Method for oral administration of buspirone and nefazodone |
| DE69930952T2 (de) * | 1998-11-02 | 2006-08-31 | Alza Corp., Mountain View | Verfahren und Vorrichtung zur kontrollierten Abgabe pharmazeutischer Mittel sowie Dosierungsform hierfür |
| US6586437B2 (en) | 1999-04-09 | 2003-07-01 | Sepracor Inc. | (S)-hydroxynefazodone antipsychotic therapy |
| US6469008B2 (en) | 1999-04-09 | 2002-10-22 | Sepracor Inc. | (R)-hydroxynefazodone antipsychotic therapy |
| EP1171133B1 (de) | 1999-04-09 | 2006-06-21 | Sepracor Inc. | R-hydroxynefazodon |
| JP2002541192A (ja) | 1999-04-09 | 2002-12-03 | セプラコール， インク． | Ｓ−ヒドロキシネファゾドン |
| EP1471913A2 (de) * | 2002-01-18 | 2004-11-03 | Hypnion Inc. | Behandlung von schlafstörungen mit schlaf-target-modulatoren |
| GB0306604D0 (en) * | 2003-03-21 | 2003-04-30 | Curidium Ltd | Second medical use |
| WO2005060968A1 (en) * | 2003-12-11 | 2005-07-07 | Sepracor Inc. | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| CA2567249A1 (en) * | 2004-04-19 | 2006-10-05 | Jds Pharmaceuticals, Llc | Lithium combinations, and uses related thereto |
| US20100227916A1 (en) * | 2006-05-19 | 2010-09-09 | Somaxon Pharmaceuticals, Inc | N-desmethyl-doxepin and methods of using the same to treat sleep disorders |
| WO2007136845A2 (en) | 2006-05-19 | 2007-11-29 | Somaxon Pharmaceuticals, Inc. | Low-dose doxepin for treatment of sleep disorders in elderly patients |
| US20100179215A1 (en) | 2006-05-19 | 2010-07-15 | Somaxon Pharmaceuticals, Inc. | Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
| US20100179214A1 (en) | 2006-05-19 | 2010-07-15 | Somaxon Pharmaceuticals, Inc. | Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
| CA2687118A1 (en) * | 2006-05-19 | 2007-12-13 | Somaxon Pharmaceuticals, Inc. | Methods of using low-dose doxepin for the improvement of sleep |
| WO2008011150A1 (en) * | 2006-07-20 | 2008-01-24 | Somaxon Pharmaceuticals, Inc. | Methods of improving the pharmacokinetics of doxepin |
| US20080182890A1 (en) * | 2006-10-04 | 2008-07-31 | Somaxon Pharmaceuticals, Inc. | Methods of using low-dose doxepin for the improvement of sleep |
| US20100105614A1 (en) | 2006-10-25 | 2010-04-29 | Somaxon Pharmaceuticals, Inc. | Ultra low dose doxepin and methods of using the same to treat sleep disorders |
| WO2008070795A2 (en) | 2006-12-06 | 2008-06-12 | Somaxon Pharmaceuticals, Inc. | Combination therapy using low-dose doxepin for the improvement of sleep |
| EP2148659A2 (de) | 2007-04-13 | 2010-02-03 | Somaxon Pharmaceuticals, Inc. | Niedrigdosierte doxepin-formulierungen |
| WO2009111031A2 (en) * | 2008-03-04 | 2009-09-11 | Intra-Cellular Therapies, Inc. | Methods of treating vasomotor symptoms |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4338317A (en) * | 1981-03-16 | 1982-07-06 | Mead Johnson & Company | Phenoxyethyl-1,2,4,-triazol-3-one antidepressants |
-
1990
- 1990-12-03 US US07/620,696 patent/US5116852A/en not_active Expired - Lifetime
-
1991
- 1991-11-07 JP JP3350548A patent/JP3062974B2/ja not_active Expired - Fee Related
- 1991-11-08 MX MX9101994A patent/MX9101994A/es not_active IP Right Cessation
- 1991-11-27 CA CA002056201A patent/CA2056201A1/en not_active Abandoned
- 1991-11-28 IL IL10018391A patent/IL100183A/en not_active IP Right Cessation
- 1991-11-29 ES ES91120587T patent/ES2087217T3/es not_active Expired - Lifetime
- 1991-11-29 DE DE69118859T patent/DE69118859T2/de not_active Expired - Fee Related
- 1991-11-29 DK DK91120587.0T patent/DK0493687T3/da active
- 1991-11-29 EP EP91120587A patent/EP0493687B1/de not_active Expired - Lifetime
- 1991-11-29 AT AT91120587T patent/ATE136777T1/de not_active IP Right Cessation
-
1996
- 1996-04-22 GR GR950403454T patent/GR3019692T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL100183A (en) | 1996-12-05 |
| US5116852A (en) | 1992-05-26 |
| MX9101994A (es) | 1992-06-01 |
| EP0493687B1 (de) | 1996-04-17 |
| DE69118859D1 (de) | 1996-05-23 |
| DK0493687T3 (da) | 1996-05-13 |
| EP0493687A2 (de) | 1992-07-08 |
| DE69118859T2 (de) | 1996-09-05 |
| JP3062974B2 (ja) | 2000-07-12 |
| ES2087217T3 (es) | 1996-07-16 |
| EP0493687A3 (en) | 1992-07-22 |
| GR3019692T3 (en) | 1996-07-31 |
| JPH04300873A (ja) | 1992-10-23 |
| CA2056201A1 (en) | 1992-06-04 |
| IL100183A0 (en) | 1992-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69118859D1 (de) | Behandlung von Schlafstörungen unter Verwendung bestimmter Antidepressiva, z.B. Nefazodon | |
| DE59600105D1 (de) | Verwendung von Adamantan-Derivaten zur Behandlung von Tinnitus | |
| ATE206919T1 (de) | Verwendung des wirkstoffs flupirtin zur herstellung eines arzneimittels zur bekämpfung von muskelverspannungen | |
| DE69200675D1 (de) | Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen. | |
| DE3788984D1 (de) | Verwendung von Prostaglandin-D2-aktiven-Substanzen zur Behandlung von Augen-Hypertension und von Glaukom. | |
| DE69709458D1 (de) | Verwendung des glialen, neurotrophen faktors (gdnf) zur behandlung von gehörstörungen | |
| DE69530933D1 (de) | Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis | |
| DE69212620D1 (de) | Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie | |
| DE69127694D1 (de) | Herstellung und verwendung von transfer-faktor | |
| ATE206708T1 (de) | Benzimidazolonderivate mit zentraler dopaminerger aktivität | |
| DE69130497D1 (de) | Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis | |
| DE69829202D1 (de) | Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen | |
| DE59206872D1 (de) | Verwendung von torasemid zur behandlung von hirnödemen | |
| ATE113591T1 (de) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva. | |
| DK671087D0 (da) | Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner som antikonvulsiva | |
| ATE116854T1 (de) | Verwendung von buspiron in schlaf-apnoe. | |
| DE3784768D1 (de) | Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen. | |
| ATE116851T1 (de) | 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung in der behandlung neurodegenerativer beschwerden. | |
| ES2053579T3 (es) | Nuevas fenilureas. | |
| IT1225483B (it) | Protesi ortopedica, particolarmente per la testa del femore. | |
| ATE229336T1 (de) | Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern | |
| DE69124415D1 (de) | Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen | |
| DE69027577D1 (de) | Verwendung von Benzothiazepinen zur Herstellung von Arzneimitteln zur Behandlung von epileptischen Anfällen | |
| DE58906618D1 (de) | Strobilurinderivate, ihre Herstellung und Verwendung. | |
| DE59504374D1 (de) | Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |